Sign in

Publications

Search in 13066 publications:

RSS
Time frame
13066 Publication(s)
Aug 19, 2019
New clinical guidelines on the spinal stabilisation of adult trauma patients - consensus and evidence based.
Maschmann C, Jeppesen E, Rubin M, Barfod C. New clinical guidelines on the spinal stabilisation of adult trauma patients - consensus and evidence based. Scand J Trauma Resusc Emerg Med 2019; 27:77.
Aug 19, 2019
New clinical guidelines on the spinal stabilisation of adult trauma patients - consensus and evidence based.
Aug 19, 2019

Scand J Trauma Resusc Emerg Med 2019; 27:77

Maschmann Christian, Jeppesen Elisabeth, Rubin Monika Afzali, Barfod Charlotte

more
Aug 19, 2019
Den akutte patient
Maschmann C. Den akutte patient - Akutte smerter, vurdering og behandling. In: Den akutte patient. 4Copenhagen: Gyldendal, 2019. ISBN 9788762818941. pp. 503-522.
Aug 19, 2019
Den akutte patient
Aug 19, 2019

Gyldendal, ISBN 9788762818941

Maschmann Christian

more
Aug 19, 2019
Den akutte patient
Maschmann C. Den akutte patient - Prehospital behandling og transport af patienter. In: Den akutte patient. 4Copenhagen: Gyldendal, 2019. ISBN 9788762818941. pp. 537-547.
Aug 19, 2019
Den akutte patient
Aug 19, 2019

Gyldendal, ISBN 9788762818941

Maschmann Christian

more
Aug 18, 2019
Contralateral MRI scan can be used reliably for three-dimensional meniscus sizing - Retrospective analysis of 160 healthy menisci
Beeler S, Vlachopoulos L, Jud L, Sutter R, Fürnstahl P, Fucentese S. Contralateral MRI scan can be used reliably for three-dimensional meniscus sizing - Retrospective analysis of 160 healthy menisci. Knee 2019; 26:954-961.
Aug 18, 2019
Contralateral MRI scan can be used reliably for three-dimensional meniscus sizing - Retrospective analysis of 160 healthy menisci
Aug 18, 2019

Knee 2019; 26:954-961

Beeler Silvan, Vlachopoulos Lazaros, Jud Lukas, Sutter Reto, Fürnstahl Philipp, Fucentese Sandro F

more
Aug 16, 2019
Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive, Early Breast Cancer
Buechler S, Badve S, Leyland-Jones B, Viale G, Kammler R, Thürlimann B, Willis S, Gökmen-Polar Y, Gray K, Regan M. Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive, Early Breast Cancer. JNCI Cancer Spectr 2019; 3:pkz051.
Aug 16, 2019
Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive, Early Breast Cancer
Aug 16, 2019

JNCI Cancer Spectr 2019; 3:pkz051

Buechler Steven A, Badve Sunil S, Leyland-Jones Brian, Viale Giuseppe, Kammler Rosita, Thürlimann Beat, Willis Scooter, Gökmen-Polar Yesim, Gray Kathryn P, Regan Meredith M

more
Aug 16, 2019
Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade
Bochem J, Weide B, Pawelec G, Garbe C, Meier F, Terheyden P, Uslu U, Wagner N, Eigentler T, Soffel D, Spreuer J, Amaral T, Zelba H, Wistuba-Hamprecht K. Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade. PloS one 2019; 14:e0221301.
Aug 16, 2019
Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade
Aug 16, 2019

PloS one 2019; 14:e0221301

Bochem Jonas, Weide Benjamin, Pawelec Graham, Garbe Claus, Meier Friedegund, Terheyden Patrick, Uslu Ugur, Wagner Nikolaus, Eigentler Thomas, Soffel Daniel, Spreuer Janine, Amaral Teresa, Zelba Henning, Wistuba-Hamprecht Kilian

more
Aug 13, 2019
Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses
Rieckmann M, van der Laan A, Piek J, Koch C, Wester H, Lapa C, Bauer W, Ludewig B, Friedman N, Frantz S, Hofmann U, Krijnen P, Niessen H, Delgobo M, Gaal C, Büchner L, Steinau P, Reshef D, Gil Cruz C, Ter Horst E, Kircher M, Reiter T, Heinze K, Ramos G. Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses. J Clin Invest 2019; 130
Aug 13, 2019
Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses
Aug 13, 2019

J Clin Invest 2019; 130

Rieckmann Max, van der Laan Anja M, Piek Jan J, Koch Charlotte, Wester Hans-Jürgen, Lapa Constantin, Bauer Wolfgang R, Ludewig Burkhard, Friedman Nir, Frantz Stefan, Hofmann Ulrich, Krijnen Paul Aj, Niessen Hans Wm, Delgobo Murilo, Gaal Chiara, Büchner Lotte, Steinau Philipp, Reshef Dan, Gil Cruz Cristina, Ter Horst Ellis N, Kircher Malte, Reiter Theresa, Heinze Katrin G, Ramos Gustavo Campos

more
Aug 13, 2019
Antikonzeption nach tiefer Venethrombose
Kühn-Lichtenberg A (2019). Antikonzeption nach tiefer Venethrombose. Presented at: Alice Kühn-Lichtenberg, Ärztefortbildung Frauenklinik KSSG
Aug 13, 2019
Antikonzeption nach tiefer Venethrombose
Aug 13, 2019

Alice Kühn-Lichtenberg

Kühn-Lichtenberg Alice

more
Aug 11, 2019
Outcome after out-of-hospital ventricular fibrillation or pulseless ventricular tachycardia: comparison of before and after the implementation of the 2010 Guidelines in a single centre
von Hösslin T, Imboden P, Kaufmann C, Schnider T, Filipovic M. Outcome after out-of-hospital ventricular fibrillation or pulseless ventricular tachycardia: comparison of before and after the implementation of the 2010 Guidelines in a single centre. Swiss Med Wkly 2019; 149:w20101.
Aug 11, 2019
Outcome after out-of-hospital ventricular fibrillation or pulseless ventricular tachycardia: comparison of before and after the implementation of the 2010 Guidelines in a single centre
Aug 11, 2019

Swiss Med Wkly 2019; 149:w20101

von Hösslin Thomas, Imboden Paul, Kaufmann Corina, Schnider Thomas, Filipovic Miodrag

more
Aug 9, 2019
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study
Schuler M, Gajate P, Cathomas R, Rajagopalan P, Grevel J, Bender S, Boix O, Nogai H, Ocker M, Ellinghaus P, Schostak M, Park S, Cho B, Sayehli C, Navarro A, Soo R, Richly H, Cassier P, Tai D, Penel N, Nogova L, Jörger M. Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study. Lancet Oncol 2019
Aug 9, 2019
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study
Aug 9, 2019

Lancet Oncol 2019

Schuler Martin, Gajate Pablo, Cathomas Richard, Rajagopalan Prabhu, Grevel Joachim, Bender Sebastian, Boix Oliver, Nogai Hendrik, Ocker Matthias, Ellinghaus Peter, Schostak Martin, Park Se Hoon, Cho Byoung Chul, Sayehli Cyrus Michael, Navarro Alejandro, Soo Ross A, Richly Heike, Cassier Philippe Alexandre, Tai David, Penel Nicolas, Nogova Lucia, Jörger Markus

more
Aug 9, 2019
Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab
Robertz J, Andres M, Mansouri Taleghani B, Koneth I, Binet F, Kremer Hovinga J. Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab. Am J Hematol 2019; 94:E259-E261.
Aug 9, 2019
Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab
Aug 9, 2019

Am J Hematol 2019; 94:E259-E261

Robertz Judith, Andres Martin, Mansouri Taleghani Behrouz, Koneth Irene, Binet Françoise-Isabelle, Kremer Hovinga Johanna A

more
Aug 9, 2019
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients
Silzle T, Blum S, Schuler E, Kaivers J, Rudelius M, Hildebrandt B, Gattermann N, Haas R, Germing U. Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients. Blood Cancer J 2019; 9:63.
Aug 9, 2019
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients
Aug 9, 2019

Blood Cancer J 2019; 9:63

Silzle Tobias, Blum Sabine, Schuler Esther, Kaivers Jennifer, Rudelius Martina, Hildebrandt Barbara, Gattermann Norbert, Haas Rainer, Germing Ulrich

more
Aug 6, 2019
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019
Wöckel A, Rhiem K, Nitz U, Mundhenke C, Müller-Schimpfle M, Möbus V, Maass N, Lux M, Luftner D, Loibl S, Rody A, Schmidt M, Witzel I, Wenz F, Thomssen C, Stickeler E, Solomayer E, Solbach C, Sinn H, Schütz F, Schneeweiss A, Kümmel S, Kühn T, Krug D, Dall P, Budach W, Blohmer J, Bauerfeind I, Albert U, Janni W, Müller V, Thill M, Untch M, Diel I, Fasching P, Kreipe H, Kolberg-Liedtke C, Jackisch C, Huober J, Harbeck N, Hanf V, Gerber B, Friedrich M, Fehm T, Ditsch N. AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019. Breast Care (Basel) 2019; 14:224-245.
Aug 6, 2019
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019
Aug 6, 2019

Breast Care (Basel) 2019; 14:224-245

Wöckel Achim, Rhiem Kerstin, Nitz Ulrike, Mundhenke Christoph, Müller-Schimpfle Markus, Möbus Volker, Maass Nicolai, Lux Michael Patrick, Luftner Diana, Loibl Sibylle, Rody Achim, Schmidt Marcus, Witzel Isabell, Wenz Frederik, Thomssen Christoph, Stickeler Elmar, Solomayer Erich-Franz, Solbach Christine, Sinn Hans-Peter, Schütz Florian, Schneeweiss Andreas, Kümmel Sherko, Kühn Thorsten, Krug David, Dall Peter, Budach Wilfried, Blohmer Jens, Bauerfeind Ingo, Albert Ute-Susann, Janni Wolfgang, Müller Volkmar, Thill Marc, Untch Michael, Diel Ingo, Fasching Peter A, Kreipe Hans-Heinrich, Kolberg-Liedtke Cornelia, Jackisch Christian, Huober Jens, Harbeck Nadia, Hanf Volker, Gerber Bernd, Friedrich Michael, Fehm Tanja, Ditsch Nina

more
Aug 6, 2019
Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial
Iglesias J, Windecker S, Jüni P, Häner J, Cuculi F, Kaiser C, Weilenmann D, Cook S, Moarof I, Muller O, Noble S, Tüller D, Roffi M, Heg D, Pilgrim T. Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial. Circ Cardiovasc Interv 2019; 12:e008024.
Aug 6, 2019
Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial
Aug 6, 2019

Circ Cardiovasc Interv 2019; 12:e008024

Iglesias Juan F, Windecker Stephan, Jüni Peter, Häner Jonas, Cuculi Florim, Kaiser Christoph, Weilenmann Daniel, Cook Stéphane, Moarof Igal, Muller Olivier, Noble Stéphane, Tüller David, Roffi Marco, Heg Dik, Pilgrim Thomas

more
Aug 6, 2019
New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group
Marvisi C, Sinico R, Salvarani C, Jayne D, Prisco D, Terrier B, Emmi G, Vaglio A, European EGPA Study Group. New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group. Intern Emerg Med 2019; 14:1193-1197.
Aug 6, 2019
New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group
Aug 6, 2019

Intern Emerg Med 2019; 14:1193-1197

Marvisi Chiara, Sinico Renato Alberto, Salvarani Carlo, Jayne David, Prisco Domenico, Terrier Benjamin, Emmi Giacomo, Vaglio Augusto, European EGPA Study Group

more
Aug 5, 2019
Forgiveness and Reconciliation Processes in Dying Patients With Cancer
Renz M, Büche D, Reichmuth O, Schuett Mao M, Renz U, Siebenrock R, Strasser F. Forgiveness and Reconciliation Processes in Dying Patients With Cancer. Am J Hosp Palliat Care 2019:1049909119867675.
Aug 5, 2019
Forgiveness and Reconciliation Processes in Dying Patients With Cancer
Aug 5, 2019

Am J Hosp Palliat Care 2019:1049909119867675

Renz Monika, Büche Daniel, Reichmuth O, Schuett Mao M, Renz U, Siebenrock R, Strasser Florian

more
Aug 3, 2019
Ultrasonic aspiration in neurosurgery: comparative analysis of complications and outcome for three commonly used models
Henzi S, Krayenbühl N, Bozinov O, Regli L, Stienen M. Ultrasonic aspiration in neurosurgery: comparative analysis of complications and outcome for three commonly used models. Acta Neurochir (Wien) 2019; 161:2073-2082.
Aug 3, 2019
Ultrasonic aspiration in neurosurgery: comparative analysis of complications and outcome for three commonly used models
Aug 3, 2019

Acta Neurochir (Wien) 2019; 161:2073-2082

Henzi Stephanie, Krayenbühl Niklaus, Bozinov Oliver, Regli Luca, Stienen Martin N.

more
Aug 2, 2019
Factors to Consider When Assessing the Diagnostic Accuracy of Synovial Leukocyte Count in Periprosthetic Joint Infection
Ottink K, Strahm C, Muller-Kobold A, Sendi P, Wouthuyzen-Bakker M. Factors to Consider When Assessing the Diagnostic Accuracy of Synovial Leukocyte Count in Periprosthetic Joint Infection. J Bone Jt Infect 2019; 4:167-173.
Aug 2, 2019
Factors to Consider When Assessing the Diagnostic Accuracy of Synovial Leukocyte Count in Periprosthetic Joint Infection
Aug 2, 2019

J Bone Jt Infect 2019; 4:167-173

Ottink Karsten D, Strahm Carol, Muller-Kobold Anneke, Sendi Parham, Wouthuyzen-Bakker Marjan

more
Aug 1, 2019
Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer
Huober J, Hackman J, Dasappa L, Ciruelos E, Toral Pena J, Adamchuk H, Hickish T, de la Pena L, Jackisch C, Gelber R, Piccart-Gebhart M, Jouannaud C, Wildiers H, Lecocq C, Holmes E, Baselga J, de Azambuja E, Untch M, Fumagalli D, Sarp S, Láng I, Smith I, Boyle F, Xu B, Di Cosimo S. Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer. Eur J Cancer 2019; 118:169-177.
Aug 1, 2019
Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer
Aug 1, 2019

Eur J Cancer 2019; 118:169-177

Huober Jens, Hackman John, Dasappa Lokanatha, Ciruelos Eva, Toral Pena Juan Carlos, Adamchuk Hryhoriy, Hickish Tamas, de la Pena Lorena, Jackisch Christian, Gelber Richard D, Piccart-Gebhart Martine, Jouannaud Christelle, Wildiers Hans, Lecocq Christophe, Holmes Eileen, Baselga José, de Azambuja Evandro, Untch Michael, Fumagalli Debora, Sarp Severine, Láng István, Smith Ian, Boyle Frances, Xu Binghe, Di Cosimo Serena

more
Aug 1, 2019
Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial)
Hench I, Vlajnic T, Bubendorf L, Burg P, Tolnay M, Ruiz C, Rothermundt C, Püschel H, Mestre R, Mingrone W, Kremer E, Hermanns T, Hench J, Gillessen Sommer S, Fischer N, Costa L, Cathomas R, Sakk S. Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial). Cancers (Basel) 2019; 11
Aug 1, 2019
Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial)
Aug 1, 2019

Cancers (Basel) 2019; 11

Hench Ivana Bratic, Vlajnic Tatjana, Bubendorf Lukas, Burg Philippe Von, Tolnay Markus, Ruiz Christian, Rothermundt Christian, Püschel Heike, Mestre Ricardo Pereira, Mingrone Walter, Kremer Eloïse, Hermanns Thomas, Hench Jürgen, Gillessen Sommer Silke, Fischer Natalie, Costa Luigi, Cathomas Richard, Sakk Swiss Group For Clinical Cancer Research

more

We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy